3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Nanotechnology and Cardiovascular Medicine
The use of nanoparticles is revolutionizing the way we approach heart disease, offering more targeted and effective treatments. Nanotechnology and cardiovascular medicine are becoming increasingly intertwined, providing innovative solutions for drug delivery systems that directly target affected areas of the heart. By minimizing side effects and increasing the efficacy of treatments, these advances hold significant promise. Additionally, nanotechnology is improving diagnostic capabilities, allowing for earlier detection of cardiovascular conditions with greater accuracy. As research in nanomedicine continues to progress, it opens up exciting possibilities for tissue regeneration and the development of artificial blood vessels, offering hope for those with chronic cardiovascular issues.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United StatesSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation